Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?: Difference between revisions
No edit summary |
No edit summary |
||
| Line 18: | Line 18: | ||
<br /><br /> | <br /><br /> | ||
==Organizers== | |||
* PGC ELSI Program | |||
* UP Manila Research Ethics Review Board | |||
<br /><br /> | |||
==See Also== | ==See Also== | ||
[[“Ethical, Legal, Social Issues” (ELSI) Program]], [http://pgc.up.edu.ph Philippine Genome Center] | [[“Ethical, Legal, Social Issues” (ELSI) Program]], [http://pgc.up.edu.ph Philippine Genome Center] | ||
Revision as of 23:27, 26 October 2012
An ELSI Colloquium on "Disclosure of Disease Risks in Genomic Research: Under what circumstances should (not) genomic researchers disclose results about disease risks?"
10 December 2012 (Monday), 2pm
Buenafe Hall
College of Medicine
University of the Philippines - Manila
Webpage shortcut: goo.gl/xszDH
Online Registration
Resource Person
Dr Reidar K. Lie
Adjunct Research Fellow
Department of Bioethics
Clinical Center
National Institutes of Health, USA
Organizers
- PGC ELSI Program
- UP Manila Research Ethics Review Board
See Also
“Ethical, Legal, Social Issues” (ELSI) Program, Philippine Genome Center
